⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FATE News
Fate Therapeutics, Inc.
Syndigo Acquires Taggstar to Make Product Experiences Dynamic and Contextual
globenewswire.com
SJM
DOLE
SWK
CL
UL
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
FATE
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
FATE
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
prnewswire.com
FBLG
MESO
LGVN
FATE
Form 8-K
sec.gov
FATE
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
globenewswire.com
FATE
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
FATE
INDP
AMGN
NKTR
IBIO
TAK
SNY
INMB
CLMT
VERX
GTBP
BHVN
CHRS
GSK
BMY
MRK
ABBV
AZN
GILD
LLY
KYMR
REGN
SPRY
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE